MENU

ALNY Alnylam Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of therapeutics based on RNA interference

Industry Biotechnology
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALNY is expected to report earnings to rise 15.98% to -57 cents per share on February 06

Alnylam Pharmaceuticals ALNY Stock Earnings Reports
Q4'24
Est.
$-0.58
Q3'24
Beat
by $0.43
Q2'24
Beat
by $1.61
Q1'24
Beat
by $0.98
Q4'23
Beat
by $0.49
The last earnings report on October 31 showed earnings per share of -50 cents, beating the estimate of -93 cents. With 151.68K shares outstanding, the current market capitalization sits at 31.80B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ALNY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+1.06%
IONS - ALNY
48%
Loosely correlated
-1.10%
ARGX - ALNY
32%
Poorly correlated
+0.90%
DNA - ALNY
30%
Poorly correlated
+1.91%
GLYC - ALNY
30%
Poorly correlated
-2.83%
ABOS - ALNY
30%
Poorly correlated
-0.51%
More